Exploratory study of clinical effectiveness and safety of TJ-116 bukuryoingohangekobokuto for anxiety and postoperative water brash in esophageal cancer patients

Phase 4

• Conditions: Esophageal cancer

• Registration Number: JPRN-UMIN000031330
• Lead Sponsor: Department of Education and Support for Regional Medicine. Department of Kampo medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-16
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who have past history of abdominal surgery 2 Patients who have past history of ileus 3 Patients with concomitant inflammatory bowel disease such as ulcerative colitis and crohn disease 4. Eemergent surgery 5. Patients who took prohibited concomitant drugs 4 weeks before treatment 6. Patients who have past history of radiotherapy and radiation chemotherapy for esophageal cancer 7. Patients who have past history of allergy for other Kampo formulation(s) 8. Patients who have serious concomitant diseases 9. A woman who is pregnant, has a possibility of pregnancy, is within 28 days after birth, is breastfeeding 10. Dementia patients 11. Others, including patients who are unfit for the study as determined by the attending physician

Study & Design

• Study Type: Interventional
• Study Design: Not specified